Jan Rijn Zeevaart

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer

Cristina Müller, Christoph A. Umbricht, Nadezda Gracheva et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 227 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy

Nadezda Gracheva, Cristina Müller, Zeynep Talip et al. · EJNMMI Radiopharmacy and Chemistry · 2019 · 111 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms

Francesca Borgna, Stephanie Haller, Josep M. Monné Rodríguez et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

First-in-Humans Application of ¹⁶¹Tb: A Feasibility Study Using ¹⁶¹Tb-DOTATOC

Richard P. Baum, Aviral Singh, Harshad Kulkarni et al. · Journal of Nuclear Medicine · 2021 · 100 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Preclinical Evaluation of ⁶⁸Ga-Labeled 1,4,7-Triazacyclononane-1,4,7-Triacetic Acid-Ubiquicidin as a Radioligand for PET Infection Imaging

Thomas Ebenhan, Jan Rijn Zeevaart, Jacobus Venter et al. · Journal of Nuclear Medicine · 2014 · 85 citations · Full text

Medicine, Infectious Diseases, Innate Immunity +14